Radioactive Material License

03/12/2025

🚨 Exciting News from MuriPhys! 🚨

We are thrilled to announce that MuriPhys has officially received our radioactive materials license and is now fully equipped to conduct preclinical oncology studies! 🎉

With this new capability, we are expanding our services to support radiolabeled drug development, biodistribution studies, and targeted radiotherapies in oncology research. Our team is ready to collaborate on advancing cutting-edge cancer therapeutics using our state-of-the-art preclinical models and imaging techniques.

🔬 Are you looking for a preclinical CRO to support your oncology studies? Let’s connect! We’re eager to discuss how MuriPhys can help accelerate your research and bring innovative cancer treatments closer to the clinic.

📩 Reach out to us today to explore collaboration opportunities! #OncologyResearch #PreclinicalStudies #Radiopharmaceuticals #DrugDevelopment #MuriPhys